Skip to content
About us
Mission & Strategy
Our story
Our team
Inobrodib
Science
Clinical trials
Indications under investigation
For Physicians
For Patients
News
Press releases
Publications
Contact us
About us
Mission & Strategy
Our story
Our team
Inobrodib
Science
Clinical trials
Indications under investigation
For Physicians
For Patients
News
Press releases
Publications
Contact us
Linkedin
Latest press releases
View all
CellCentric Expands Leadership Team with appointment of Chief Financial and Business Officer
27 May 2025
Press Release
CellCentric secures $120 million investment to advance inobrodib for treating multiple myeloma
19 May 2025
Press Release
CellCentric Expands US Presence with New Office in Boston
2 April 2025
Press Release
Inobrodib
A first-in-class oral
anti-cancer drug
Find out more
Main Menu
About us
Mission & Strategy
Our story
Our team
Inobrodib
Science
Clinical trials
Indications under investigation
For Physicians
For Patients
News
Press releases
Publications
Contact us
Follow us on LinkedIn
